IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Haupt Pharma Merger Creates Major CMO Player in Europe

8:53 AM MDT | September 22, 2008 | Deepti Ramesh

The merger of three German contract manufacturers and developers earlier this month to form Haupt Pharma (Berlin) has created a major contract manufacturing organization (CMO) in Europe with eight production facilities, 1,500 employees, and sales of €180 million ($256 million). Invita (Plettenberg, Germany), an investment firm focused on the pharma market, owns the new company, which comprises Amareg (Regensburg), Haupt Pharma (Berlin), and Wülfing Pharma (Gronau). Amareg is mainly focused on cytostatics in film-coated tablet and capsule form as well as...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa